List of works - Qing Liu

A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase

scientific article published on 19 December 2018

A continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vivo activities

scientific article

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice

scientific article

Adenine derivatives invert high glucose-induced thioredoxin-interacting protein overexpression

scientific article published on 11 September 2018

Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2.

scientific article

Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice

scientific article

Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors

scientific article

Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor

scientific article published on 08 December 2011

Development of β-amino-carbonyl compounds as androgen receptor antagonists.

scientific article

High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis

scientific article published on 31 August 2015

High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139

scientific article

Histone lysine methyltransferases as anti-cancer targets for drug discovery

scientific article

Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography

scientific article published in Nature Communications

Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure

scientific article (publication date: September 2015)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor

scientific article published on 18 June 2021

Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery ⬇️

scientific article published on August 2, 2010

Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.

scientific article

Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice

scientific article (publication date: 2010)

Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24

scientific article published on 13 May 2022

W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.

scientific article published on 15 May 2017

List of works by Qing Liu

A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase

A continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vivo activities

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice

Adenine derivatives invert high glucose-induced thioredoxin-interacting protein overexpression

Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2.

Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice

Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors

Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor

Development of β-amino-carbonyl compounds as androgen receptor antagonists.

High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis

High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139

Histone lysine methyltransferases as anti-cancer targets for drug discovery

Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography

Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor

Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery ⬇️

Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.

Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice

Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24

W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.